At AAPS, Markus Stübchen of Roche presented on their use of the Vanrx SA25 Aseptic Filling Workcell.

Roche presents on the role of robotics in their manufacturing strategy

November 22, 2018 - Featured

On November 6, Mr. Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation at AAPS described how Roche and Genentech will use Vanrx’s SA25 Aseptic Filling Workcell as part of a “network” strategy.

Read More

News | Vanrx

Roche presents on the role of robotics in their manufacturing strategy

November 22, 2018 - Featured

On November 6, Mr. Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation at AAPS described how Roche and Genentech will use Vanrx's SA25 Aseptic Filling Workcell as part of a "network" strategy.

Bring new drug products to market faster

October 15, 2018 - Blog, Featured

In a June 2018 interview with McKinsey & Company, Esteban Santos, executive vice president for operations at Amgen, described the current state of the biopharma market and the resulting need for companies to bring new drug products to market faster. This blog will explore how Vanrx’s aseptic processing machines can accelerate drug development, build facilities faster and respond faster to changing market conditions.

The future is gloveless for biopharma aseptic filling

September 25, 2018 - Article, Featured

Vanrx was recently featured in the leading international publication Cleanroom Technology for redesigning the aseptic filling process with our gloveless isolator technology. This article explains how the future of aseptic filling is shifting away from glove ports / conventional isolators and focusing on gloveless isolators, such as Vanrx Aseptic Filling Workcells. The built-in flexibility and aseptic assurance provided by these new aseptic filling technologies are a global solution for changing pharmaceutical market demands.

Manual aseptic processing needs to end

September 7, 2018 - Blog, cell therapy, Featured, Gene therapy

Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.

Upcoming Events

ISPE Biopharmaceutical Manufacturing Conference

Dec 10 - Dec 12, 2018

Huntington Beach, CA, USA

401

PDA Annual Meeting

Mar 11 - Mar 13, 2019

San Diego, CA, USA

215

Bioprocess International West

Mar 11 - Mar 14, 2019

Santa Clara, CA, USA

221

Interphex

Apr 2 - Apr 4, 2019

New York, NY, USA

3805

Pharma-Kongress

Apr 9 - Apr 10, 2019

Düsseldorf, Germany

80

BIO International Convention

Jun 4 - Jun 6, 2019

Philadelphia, MA, USA

3701

Bioprocess International

Sep 9 - Sep 12, 2019

Boston, MA, USA

1314

ISPE Boston Product Show

Sep 18 - Sep 18, 2019

Foxborough, MA, USA

E152 (East Hall)

CPhI / P-MEC Worldwide 2019

Nov 5 - Nov 7, 2019

Frankfurt, Germany

110B22